Lisinopril
- Product NDC
- 0615-7641
- 11-digit product format
- 006157641
- Labeler code
- 0615
- Product ID
- 0615-7641_35e2befc-faf9-486b-97d3-71f98e7e6982
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lisinopril
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- NCS HealthCare of KY, Inc dba Vangard Labs
- Application
- ANDA078402
- Marketing category
- ANDA
- Marketing start
- 2007-04-19
- Marketing end
- 0000-00-00
- Substance
- LISINOPRIL
- Active strength
- 10 mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0615-7641-05 | 2022-11-09 | C162847 | 48780-1 | 9d75b9d1-0b97-f424-e053-dadaa90a57ce | e9385674-c074-4854-9b5c-655846cd8e09 |
| 0615-7641-31 | 2022-11-09 | C162847 | 48780-1 | 9d75b9d1-0b97-f424-e053-dadaa90a57ce | e9385674-c074-4854-9b5c-655846cd8e09 |
| 0615-7641-39 | 2022-11-09 | C162847 | 48780-1 | 9d75b9d1-0b97-f424-e053-dadaa90a57ce | e9385674-c074-4854-9b5c-655846cd8e09 |
| 0615-7641-05 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-0b97-f424-e053-dadaa90a57ce | e9385674-c074-4854-9b5c-655846cd8e09 |
| 0615-7641-31 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-0b97-f424-e053-dadaa90a57ce | e9385674-c074-4854-9b5c-655846cd8e09 |
| 0615-7641-39 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-0b97-f424-e053-dadaa90a57ce | e9385674-c074-4854-9b5c-655846cd8e09 |